Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Ascend Tapio Sarl’s holding in Aiforia Technologies Plc
Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Ascend Tapio Sarl’s holding in Aiforia Technologies Plc
Aiforia Technologies Plc, Company release, May 29, 2025 11:30a.m. EEST
Ascend Tapio Sarl has informed Aiforia Technologies Plc that it has crossed below the 15% disclosure threshold on holding in shares and voting rights in Aiforia. According to the announcement, the holding passed underneath the threshold on May 28, 2025.
According to the notification, the reason for the notification was the event changing the breakdown of shares or voting rights.
Total positions of Ascend Tapio Sarl subject to the notification:
| % shares and voting rights | % of shares and voting rights through financial instruments | Total of both in % | Total number of shares and voting rights of issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 14.18% | 14.18% | 31,464,954 | |
| Positions of previous notification (if applicable) | 15.40% | 15.40% | 28,844,467 |
A: Shares and voting rights
| Number of shares and voting rights | % of shares and voting rights | |||
| Class/type of shares, ISIN code | Direct (AML 9:5) | Indirect (AML 9:6 and 9:7) | Direct (AML 9:5) | Indirect (AML 9:6 and 9:7) |
| FI4000507934 | 4,461,150 | 14.18% | ||
| SUBTOTAL | 4,461,150 | 14.18% | ||
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:
| Name | % of shares and voting rights | % of shares and voting rights through financial instruments | Total of both |
| Kin Lai Monita Au | 14.18% | 4,461,150 | |
| Ascend Artemis Sarl | 14.18% | 4,461,150 | |
| Ascend Tapio Sarl | 14.18% | 4,461,150 |
Further inquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc
tel. +358405009878
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.
Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.
Find out more at www.aiforia.com